Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This study identified a preferential interaction between the frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS) associated splicing protein TDP-43.”
In the citing paper
“Previously, we used tagged PABPN1 constructs to perform immunoprecipitation and comparative proteomics to examine PABPN1 and expanded PABPN1 binding proteins in murine limb muscle [24].”
In the citing paper
“Expression of expanded PABPN1 lead to intron retention in the transcript encoding sortillin-1 (SORT1) and resulted in loss of SORT1 function.”
In the citing paper
“Indeed, previous studies using glycerol gradient centrifugation found that PABPN1 is detected in higher molecular weight complexes, and these complexes are larger in myotubes expressing alanine-expanded PABPN1 [24,36].”
In the citing paper
“Finally, we detected multiple overlapping proteins and pathways detected in our previous study of immunoprecipitated tagged PABPN1 in mouse skeletal muscle [24,36].”
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exercise, GLUT4, and skeletal muscle glucose uptake
Richter, E. A., & Hargreaves, M. (2013) · Physiological Reviews · doi:10.1152/physrev.00038.2012 · Cited by 1,407 · cited 1×
“SORT1 regulates GLUT4 (50), which modulates cellular glucose uptake (53).”
BackgroundLong pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2779 · Cited by 1,335
Fan, X. C., & Steitz, J. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3448 · Cited by 866
Research works printed but not linked: 87
- Amiel, 2004, Polyalanine expansions in human, Hum. Mol. Genet, 13, R235, 10.1093/hmg/ddh251 · DOI · Paper page
- Messaed, 2009, Molecular mechanisms underlying polyalanine diseases, Neurobiol. Dis, 34, 397, 10.1016/j.nbd.2009.02.013 · DOI
- Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet, 18, 164, 10.1038/ng0298-164 · DOI · Paper page
- Jouan, 2014, An 18 alanine repeat in a severe form of oculopharyngeal muscular dystrophy, Can. J. Neurol. Sci, 41, 508, 10.1017/S0317167100018588 · DOI · Paper page
- Albrecht, 2005, The other trinucleotide repeat: polyalanine expansion disorders, Curr. Opin. Genet. Dev, 15, 285, 10.1016/j.gde.2005.04.003 · DOI · Paper page
- Uyama, 2000, Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy, Muscle Nerve, 23, 1549, 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0 · DOI
- Calado, 2000, Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA, Hum. Mol. Genet, 9, 2321, 10.1093/oxfordjournals.hmg.a018924 · DOI · Paper page
- Messaed, 2007, Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy, Neurobiol. Dis, 26, 546, 10.1016/j.nbd.2007.02.004 · DOI
- Mankodi, 2012, Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy, Neurobiol. Dis, 45, 539, 10.1016/j.nbd.2011.09.010 · DOI
- Dion, 2005, Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice, Neurobiol. Dis, 18, 528, 10.1016/j.nbd.2004.09.021 · DOI
- Berciano, 2004, Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus, Hum. Mol. Genet, 13, 829, 10.1093/hmg/ddh101 · DOI
- Villagra, 2008, Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions, Mol. Cell. Neurosci, 37, 622, 10.1016/j.mcn.2007.12.012 · DOI
- Corbeil-Girard, 2005, PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions, Neurobiol. Dis, 18, 551, 10.1016/j.nbd.2004.10.019 · DOI
- Fan, 2003, HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy, Can. J. Neurol. Sci, 30, 244, 10.1017/S0317167100002675 · DOI
- Apponi, 2013, Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle, Skeletal Muscle, 3, 23, 10.1186/2044-5040-3-23 · DOI · Paper page
- Phillips, 2018, Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR, Nucleic Acids Res, 46, 7643, 10.1093/nar/gky535 · DOI · Paper page
- Gerstberger, 2014, Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease, Adv. Exp. Med. Biol, 825, 1, 10.1007/978-1-4939-1221-6_1 · DOI · Paper page
- Banerjee, 2013, PABPN1: molecular function and muscle disease, FEBS J, 280, 4230, 10.1111/febs.12294 · DOI · Paper page
- Kühn, 2009, Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor, J. Biol. Chem, 284, 22803, 10.1074/jbc.M109.018226 · DOI · Paper page
- Jenal, 2012, The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, 149, 538, 10.1016/j.cell.2012.03.022 · DOI · Paper page
- de Klerk, 2012, Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation, Nucleic Acids Res, 40, 9089, 10.1093/nar/gks655 · DOI · Paper page
- Apponi, 2010, Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis, Hum. Mol. Genet, 19, 1058, 10.1093/hmg/ddp569 · DOI · Paper page
- Calado, 2000, Deciphering the cellular pathway for transport of poly(A)-binding protein II, RNA, 6, 245, 10.1017/S1355838200991908 · DOI
- Ishigaki, 2001, Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20, Cell, 106, 607, 10.1016/S0092-8674(01)00475-5 · DOI · Paper page
- Abu-Baker, 2007, Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies, Biochim. Biophys. Acta, 1772, 173, 10.1016/j.bbadis.2006.10.003 · DOI
- Goodman, 1997, Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract, Proc. Natl. Acad. Sci. U.S.A, 94, 7458, 10.1073/pnas.94.14.7458 · DOI · Paper page
- Tavanez, 2009, Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1, PLoS One, 4, e6418, 10.1371/journal.pone.0006418 · DOI
- Kim, 2001, The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression, Hum. Mol. Genet, 10, 1129, 10.1093/hmg/10.11.1129 · DOI
- Banerjee, 2017, Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing, Nucleic Acids Res, 45, 10706, 10.1093/nar/gkx786 · DOI · Paper page
- Küsters, 2009, TDP-43 accumulation is common in myopathies with rimmed vacuoles, Acta Neuropathol, 117, 209, 10.1007/s00401-008-0471-2 · DOI · Paper page
- Chou, 2015, PABPN1 suppresses TDP-43 toxicity in ALS disease models, Hum. Mol. Genet, 24, 5154, 10.1093/hmg/ddv238 · DOI
- Vogler, 2018, TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle, Nature, 563, 508, 10.1038/s41586-018-0665-2 · DOI · Paper page
- Vest, 2017, Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology, Hum. Mol. Genet, 26, 3235, 10.1093/hmg/ddx206 · DOI · Paper page
- Davies, 2005, Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice, Nat. Med, 11, 672, 10.1038/nm1242 · DOI · Paper page
- Randolph, 2014, Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner, J. Physiol, 592, 5301, 10.1113/jphysiol.2014.280420 · DOI · Paper page
- Vest, 2015, An antibody to detect alanine-expanded PABPN1: a new tool to study oculopharyngeal muscular dystrophy, J. Neuromuscul. Dis, 2, 439, 10.3233/JND-150111 · DOI · Paper page
- Kühn, 2003, The RNA binding domains of the nuclear poly(A)-binding protein, J. Biol. Chem, 278, 16916, 10.1074/jbc.M209886200 · DOI
- Kühn, 2004, Structure and function of poly(A) binding proteins, Biochim. Biophys. Acta, 1678, 67, 10.1016/j.bbaexp.2004.03.008 · DOI · Paper page
- Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108 · DOI · Paper page
- Cykowski, 2018, Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis, Acta Neuropathol. Commun, 6, 28, 10.1186/s40478-018-0528-y · DOI
- Cortese, 2014, Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy, Neurobiol. Aging, 35, 1491, 10.1016/j.neurobiolaging.2013.12.029 · DOI
- Cutler, 2017, Biochemical isolation of myonuclei from mouse skeletal muscle tissue, Bio Protocol, 7, e2654, 10.21769/BioProtoc.2654 · doi:10.21769/bioprotoc.2654
- Chal, 2017, Making muscle: skeletal myogenesis in vivo and in vitro, Development, 144, 2104, 10.1242/dev.151035 · DOI · Paper page
- Cohen, 2012, Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking, EMBO J, 31, 1241, 10.1038/emboj.2011.471 · DOI · Paper page
- Tollervey, 2011, Characterizing the RNA targets and position-dependent splicing regulation by TDP-43, Nat. Neurosci, 14, 452, 10.1038/nn.2778 · DOI · Paper page
- Ricketts, 2014, A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects, PLoS One, 9, e85962, 10.1371/journal.pone.0085962 · DOI
- Afroz, 2017, Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation, Nat. Commun, 8, 45, 10.1038/s41467-017-00062-0 · DOI · Paper page
- Mohagheghi, 2016, TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor, Hum. Mol. Genet, 25, 534, 10.1093/hmg/ddv491 · DOI · Paper page
- Ariga, 2008, Functional role of sortilin in myogenesis and development of insulin-responsive glucose transport system in C2C12 myocytes, J. Biol. Chem, 283, 10208, 10.1074/jbc.M710604200 · DOI · Paper page
- Shi, 2005, Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes, Dev. Cell, 9, 99, 10.1016/j.devcel.2005.04.004 · DOI · Paper page
- Carrasquillo, 2010, Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma, Am. J. Hum. Genet, 87, 890, 10.1016/j.ajhg.2010.11.002 · DOI · Paper page
- Hu, 2010, Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin, Neuron, 68, 654, 10.1016/j.neuron.2010.09.034 · DOI · Paper page
- Holler, 2017, Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations, eNeuro, 4, 10.1523/ENEURO.0100-17.2017 · DOI · Paper page
- Zheng, 2011, C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking, PLoS One, 6, e21023, 10.1371/journal.pone.0021023 · DOI · Paper page
- Tavanez, 2005, In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1, RNA, 11, 752, 10.1261/rna.7217105 · DOI
- Raz, 2011, Reversible aggregation of PABPN1 pre-inclusion structures, Nucleus, 2, 208, 10.4161/nucl.2.3.15736 · DOI · Paper page
- Fronz, 2011, Arginine methylation of the nuclear poly(a) binding protein weakens the interaction with its nuclear import receptor, transportin, J. Biol. Chem, 286, 32986, 10.1074/jbc.M111.273912 · DOI
- Aktas, 2017, DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome, Nature, 544, 115, 10.1038/nature21715 · DOI · Paper page
- Moore, 2018, Csde1 binds transcripts involved in protein homeostasis and controls their expression in an erythroid cell line, Sci. Rep, 8, 2628, 10.1038/s41598-018-20518-7 · DOI
- Ma, 1997, The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA, Nucleic Acids Res, 25, 3564, 10.1093/nar/25.18.3564 · DOI · Paper page
- Medghalchi, 2001, Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability, Hum. Mol. Genet, 10, 99, 10.1093/hmg/10.2.99 · DOI · Paper page
- Kim, 2005, Mammalian Staufen1 recruits Upf1 to specific mRNA 3′UTRs so as to elicit mRNA decay, Cell, 120, 195, 10.1016/j.cell.2004.11.050 · DOI · Paper page
- Koh, 2014, Repetitive RNA unwinding by RNA helicase A facilitates RNA annealing, Nucleic Acids Res, 42, 8556, 10.1093/nar/gku523 · DOI
- Kamelgarn, 2016, Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS, Biochim. Biophys. Acta, 1862, 2004, 10.1016/j.bbadis.2016.07.015 · DOI · Paper page
- Chi, 2018, Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins, Sci. Rep, 8, 8755, 10.1038/s41598-018-27136-3 · DOI
- Pauzner, 1991, Mitochondrial abnormalities in oculopharyngeal muscular dystrophy, Muscle Nerve, 14, 947, 10.1002/mus.880141004 · doi:10.1002/mus.880141004
- Chartier, 2015, Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis, PLoS Genet, 11, e1005092, 10.1371/journal.pgen.1005092 · DOI
- Franco-Iborra, 2018, Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson's disease and Huntington's disease, Front. Neurosci, 12, 342, 10.3389/fnins.2018.00342 · DOI · Paper page
- Toriumi, 2008, Expression of polyalanine stretches induces mitochondrial dysfunction, J. Neurosci. Res, 86, 1529, 10.1002/jnr.21619 · DOI
- Toriumi, 2009, Polyalanine tracts directly induce the release of cytochrome c, independently of the mitochondrial permeability transition pore, leading to apoptosis, Genes Cells, 14, 751, 10.1111/j.1365-2443.2009.01307.x · DOI
- Lopez-Gonzalez, 2016, Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons, Neuron, 92, 383, 10.1016/j.neuron.2016.09.015 · DOI · Paper page
- Wang, 2016, The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity, Nat. Med, 22, 869, 10.1038/nm.4130 · DOI · Paper page
- Davis, 2018, TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics, Neurosci. Lett, 678, 8, 10.1016/j.neulet.2018.04.053 · DOI · Paper page
- Ling, 2010, ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS, Proc. Natl. Acad. Sci. U.S.A, 107, 13318, 10.1073/pnas.1008227107 · DOI · Paper page
- Cohen, 2011, TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies, Trends Mol. Med, 17, 659, 10.1016/j.molmed.2011.06.004 · DOI · Paper page
- Kim, 2010, Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA, J. Biol. Chem, 285, 34097, 10.1074/jbc.M110.154831 · DOI · Paper page
- Johnson, 2014, Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis, Nat. Neurosci, 17, 664, 10.1038/nn.3688 · DOI · Paper page
- Tada, 2018, Matrin 3 is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis, Am. J. Pathol, 188, 507, 10.1016/j.ajpath.2017.10.007 · DOI
- Weihl, 2008, TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia, J. Neurol. Neurosurg. Psychiatry, 79, 1186, 10.1136/jnnp.2007.131334 · DOI · Paper page
- Lei, 1999, The RAP74 subunit of human transcription factor IIF has similar roles in initiation and elongation, Mol. Cell. Biol, 19, 8372, 10.1128/MCB.19.12.8372 · DOI
- Renz, 1996, Purification and molecular cloning of the scaffold attachment factor B (SAF-B), a novel human nuclear protein that specifically binds to S/MAR-DNA, Nucleic Acids Res, 24, 843, 10.1093/nar/24.5.843 · DOI
- Dahl, 1998, The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42, Oncogene, 16, 1579, 10.1038/sj.onc.1201687 · DOI
- Figueroa, 2004, Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-β1 and bone morphogenetic protein-2 in C2C12 cells, Exp. Cell Res, 296, 163, 10.1016/j.yexcr.2004.01.025 · DOI
- Yamaguchi, 2016, FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription, Sci. Rep, 6, 35195, 10.1038/srep35195 · DOI
- Donovan, 2013, Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease, Alzheimers Res. Ther, 5, 32, 10.1186/alzrt186 · DOI · Paper page
- Zambon, 2012, GO-Elite: a flexible solution for pathway and ontology over-representation, Bioinformatics, 28, 2209, 10.1093/bioinformatics/bts366 · DOI · Paper page
- Wobst, 2017, Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant, PLoS One, 12, e0177181, 10.1371/journal.pone.0177181 · DOI
Cited by
Mezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E. (2026) · PLOS Genetics · doi:10.1371/journal.pgen.1011743 · Cited by 7
Self-citation
Metadata
- Authors
- Banerjee, A., Phillips, B. L., Deng, Q., Seyfried, N. T., Pavlath, G. K., Vest, K. E., & Corbett, A. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 294
- Issue
- 18
- Pages
- 7360-7376
- ISSN
- 0021-9258
- Cited by
- 13
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 483 d)
- Funders
- HHS | National Institutes of Health (5RO1AR061987, 5F32AR068207)
- Muscular Dystrophy Association (255856, 422006)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.